An antibody, wherein the antibody comprises: (a) a heavy chain variable domain and a light chain variable domain selected from the group of: (i) SEQ ID NO: 5 and SEQ ID NO: 6, respectively; (ii) SEQ ID NO: 7 and SEQ ID NO: 8, respectively; (iii) SEQ ID NO: 9 and SEQ ID NO: 10, respectively; (iv) SEQ ID NO: 11 and SEQ ID NO: 12, respectively; (v) SEQ ID NO: 13 and SEQ ID NO: 14, respectively; (vi) SEQ ID NO: 15 and SEQ ID NO: 16, respectively; (vii) SEQ ID NO: 17 and SEQ ID NO: 18, respectively; (viii) SEQ ID NO: 19 and SEQ ID NO: 20, respectively; (ix) SEQ ID NO: 21 and SEQ ID NO: 22, respectively; (x) SEQ ID NO: 23 and SEQ ID NO: 24, respectively; (xi) SEQ ID NO: 25 and SEQ ID NO: 26, respectively; (xii) SEQ ID NO: 27 and SEQ ID NO: 28, respectively; (xiii) SEQ ID NO: 29 and SEQ ID NO: 30, respectively; (xiv) SEQ ID NO: 31 and SEQ ID NO: 32, respectively; (xv) SEQ ID NO: 33 and SEQ ID NO: 34, respectively; and (b) a heavy chain CH1-CH2-CH3 sequence of SEQ ID NO: 155 or SEQ ID NO: 189 comprising one or more of the following: (i) a lysine to cysteine substitution at amino acid position 105 and deletion of a threonine at amino acid positions 106 and 108; (ii) a methionine to tyrosine substitution at amino acid position 135, a serine to threonine substitution at amino acid position 137, and a threonine to glutamic acid substitution at amino acid position 139; (iii) a methionine to leucine substitution at amino acid position 311 and an asparagine to serine substitution at amino acid position 317; and (iv) an alanine to a cysteine substitution at amino acid position 1; and/or a light chain C L sequence of SEQ ID NO: 157 comprising a valine to cysteine substitution at amino acid position 98. (a) a heavy chain variable domain and a light chain variable domain selected from the group of: (i) SEQ ID NO: 5 and SEQ ID NO: 6, respectively; (ii) SEQ ID NO: 7 and SEQ ID NO: 8, respectively; (iii) SEQ ID NO: 9 and SEQ ID NO: 10, respectively; (iv) SEQ ID NO: 11 and SEQ ID NO: 12, respectively; (v) SEQ ID NO: 13 and SEQ ID NO: 14, respectively; (vi) SEQ ID NO: 15 and SEQ ID NO: 16, respectively; (vii) SEQ ID NO: 17 and SEQ ID NO: 18, respectively; (viii) SEQ ID NO: 19 and SEQ ID NO: 20, respectively; (ix) SEQ ID NO: 21 and SEQ ID NO: 22, respectively; (x) SEQ ID NO: 23 and SEQ ID NO: 24, respectively; (xi) SEQ ID NO: 25 and SEQ ID NO: 26, respectively; (xii) SEQ ID NO: 27 and SEQ ID NO: 28, respectively; (xiii) SEQ ID NO: 29 and SEQ ID NO: 30, respectively; (xiv) SEQ ID NO: 31 and SEQ ID NO: 32, respectively; (xv) SEQ ID NO: 33 and SEQ ID NO: 34, respectively; and (i) SEQ ID NO: 5 and SEQ ID NO: 6, respectively; (ii) SEQ ID NO: 7 and SEQ ID NO: 8, respectively; (iii) SEQ ID NO: 9 and SEQ ID NO: 10, respectively; (iv) SEQ ID NO: 11 and SEQ ID NO: 12, respectively; (v) SEQ ID NO: 13 and SEQ ID NO: 14, respectively; (vi) SEQ ID NO: 15 and SEQ ID NO: 16, respectively; (vii) SEQ ID NO: 17 and SEQ ID NO: 18, respectively; (viii) SEQ ID NO: 19 and SEQ ID NO: 20, respectively; (ix) SEQ ID NO: 21 and SEQ ID NO: 22, respectively; (x) SEQ ID NO: 23 and SEQ ID NO: 24, respectively; (xi) SEQ ID NO: 25 and SEQ ID NO: 26, respectively; (xii) SEQ ID NO: 27 and SEQ ID NO: 28, respectively; (xiii) SEQ ID NO: 29 and SEQ ID NO: 30, respectively; (xiv) SEQ ID NO: 31 and SEQ ID NO: 32, respectively; (xv) SEQ ID NO: 33 and SEQ ID NO: 34, respectively; and (b) a heavy chain CH1-CH2-CH3 sequence of SEQ ID NO: 155 or SEQ ID NO: 189 comprising one or more of the following: (i) a lysine to cysteine substitution at amino acid position 105 and deletion of a threonine at amino acid positions 106 and 108; (ii) a methionine to tyrosine substitution at amino acid position 135, a serine to threonine substitution at amino acid position 137, and a threonine to glutamic acid substitution at amino acid position 139; (iii) a methionine to leucine substitution at amino acid position 311 and an asparagine to serine substitution at amino acid position 317; and (iv) an alanine to a cysteine substitution at amino acid position 1; and/or (i) a lysine to cysteine substitution at amino acid position 105 and deletion of a threonine at amino acid positions 106 and 108; (ii) a methionine to tyrosine substitution at amino acid position 135, a serine to threonine substitution at amino acid position 137, and a threonine to glutamic acid substitution at amino acid position 139; (iii) a methionine to leucine substitution at amino acid position 311 and an asparagine to serine substitution at amino acid position 317; and (iv) an alanine to a cysteine substitution at amino acid position 1;